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Abstract
Introduction: Imaging-based diagnosis of intra-axial contrast-enhancing brain tumors is frequently challenging. We show
that the diagnosis of medulloblastoma (MDB) versus pilocytic astrocytoma (PA) and ependymoma (EPM) profit from
computational analyses, based on quantitative image properties (i.e. textural features from apparent diffusion coefficient
(ADC)-maps) and an automated machine learning classification (random forests (RF)). Methods: Forty patients who
were diagnosed with three types of brain tumors were included in this study: 16 with MDB, 4 with PA, and 10 EPM. Based
on the analysis of multi parametric preoperative magnetic resonance images, neuroradiologists gave a clear-cut diagnosis if
they were sure of the diagnosis; however, most diagnoses comprise several possible tumor types. To distinguish between
the named tumor types, a computer-based differential diagnosis (DD) tool was developed. Tumor lesion volumes were
manually defined using ADC-maps only. From the demarked ADC-map, texture-parameters were extracted to train RF
classifiers for pairwise DD. Performance of the RF models and reproducibility of the manual segmentation were evaluated.
Results: Neuroradiologists gave correct and clear-cut diagnoses for 31% of MDB, 14.3% of PA, and 10% of EPM. Most
diagnoses comprised several tumor types and altogether diagnoses containing the right tumor were given in 69% of true
MDB, 64% of true PA, and 30% of true EPM. Ambiguous diagnoses could be improved by RF classifiers showing the
following PA versus MDB performance: sensitivity 0.888 + 0.031, specificity 0.886 + 0.036; EPM versus MDB: sensitivity:
0.938 (95% CI ¼ (0.677, 0.997)) and specificity: 0.7 (95% CI ¼ (0.354, 0.919)); EPM versus PA: sensitivity: 0.786 (95% CI ¼
(0.488, 0.942) and specificity: 0.100 (95% CI ¼ (0.005, 0.458). An inter- and intra-rater analysis (three human raters) was
performed and the Fleiss’ kappa test revealed high inter-rater agreement of  ¼ 0.821 (p value << 0.001) and an intra-rater
agreement of ¼ 0.822 (p value << 0.001).Conclusion: In the frequent case of ambiguous neuroradiologist diagnoses, a
subsequent differential RF classification improves the diagnoses in all cases. The largest benefit is gained for the dis-
crimination PA versus MDB with an accuracy of 88.0+ 3.0% followed by EPM versus MDB with an accuracy of 84.6%.
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Introduction
Noninvasive differentiation between medulloblastoma
(MDB), pilocytic astrocytoma (PA), and ependymoma
(EPM) using conventional magnetic resonance imaging
(MRI) techniques is frequently prone to misinterpretation,
since these tumors may have similar appearance on, for
example, diffusion-weighted imaging (DWI), T2w/Fluid-
attenuated inversion recovery (FLAIR), and T1 contrast-
enhancing images. To illustrate the difficulty to distinguish
these diseases by visual inspection, Figure 1 displays the
apparent diffusion coefficient (ADC)-maps of three typical
patients suffering from the above mentioned tumor types. A
major difference between the tumor classes is achieved by
the cellular density and organization patterns, which
directly influence the diffusivity of protons in the extracel-
lular space, which is characterized by the so-called ADC.
Many studies using ADC-map information in diagnosing
brain tumors have been performed. For instance, Rumboldt
et al.1 found significant differences in ADC mean value
between PA, MDB, and EPMs. Schneider et al.2 used the
combined value of DWI and proton magnetic resonance
spectroscopy (1H-MRS) for the same differential diagnosis
(DD). Yamashita et al.3 found that minimum apparent dif-
fusion coefficient is significantly correlated with cellularity
and found differences between the tumor types. Jaremko
et al.4 showed that MDB and PA could be differentiated but
EPM could not be reliably differentiated from MDB or PA.
Gimi et al.5 used a tumor/normal brain ADC-ratio threshold
and used ratio thresholds only for tumor discrimination.
Bull et al.6 used more sophisticated ADC-based histogram
parameters to discriminate the tumors, however, on a very
small number of patients. Koral et al.7 studied the impact of
diffusion MRI on accuracy of visual diagnoses, and con-
cluded that ADC-maps help to improve the diagnosis.
Pierce and Provenzale8 also found that minimal ADC val-
ues can be used to differentiate brain tumors. Another
method for differentiating these brain tumor types was pro-
posed by Gutierrez et al.,9 using support vector machine-
based classifiers using ADC histogram features that yielded
very good discrimination among pediatric posterior fossa
tumor types, and ADC-extracted textural-features that
show promising results for further subtype discrimination.
The approach of Gutierrez et al.9 uses classification algo-
rithms applied to radiological image data for diagnosis.
Such an approach in diagnostics can be regarded as
computer-aided radiological diagnostics (CARD).
In this article, we describe a different type of CARD
method aiming at application in a clinical routine setting.
This approach is based on random forests (RF) of Brei-
man.10 Our novel semiautomatic CARD method should
enable the neuroradiologist in daily clinical routine to
obtain support for choosing the most likely diagnosis (in
this case PA, MDB, or EPM). The presented method is also
based on ADC-map features as MRI surrogate markers to
tumor-specific molecular processes. The method combines
expert-based segmentation of the complete tumor-affected
volume, with RF classification for diagnosis. Since the
contouring of the tumors is performed manually, it’s inher-
ent that the reproducibility cannot be 100%. Hence it is to
be conceivable that the RF classification performance, that
is diagnostic performance, will be randomly influenced by
this. One aim of this study is to evaluate how big the inter-
and intra-rater influence of manual segmentation is on the
RF-classification performance, in order to test the robust-
ness of the classifiers obtained.
The following research questions were investigated:
(1) how does the CARD method performs compared to
expert-based diagnosis, (2) does the intra- and inter-rater
variability in segmentation affect the RF prediction, and
(3) is it possible to improve the individual clinical diagno-
sis, without the need of additional image data, that is, by
utilizing the available digital MRI information and previ-
ously confirmed diagnoses in a quantitative way.
Figure 1. Illustrative ADC-maps of three patients suffering from (a) PA, (b) MDB, and (c) EPM. By only visual inspection, it is very
difficult to distinguish these brain tumors from each other. As shown in this article, quantitative texture parameter analysis, combined
with machine learning can improve diagnostic accuracy substantially. PA: pilocytic astrocytoma; MDB: medulloblastoma; EPM:
ependymoma.
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Methods
Included patients
Patients with newly diagnosed and histologically con-
firmed PA, MDB, or EPM, preoperatively submitted to our
institution between January 2009 and July 2015, were
included in this retrospective study. Exclusion criteria were
incomplete image acquisition and previous cranial neuro-
surgery. Quantitative brain tumor textural information of a
total of 40 patients was extracted from ADC-maps only.
The ADC-map data were either acquired in each of our
standard brain tumor protocols or from ADC-maps outside
our institution. Therefore, except for one patient, all ADC-
maps were, however, acquired on the scanners of the same
manufacturer. All clinical diagnoses, which served as
ground truth, were histologically certified.
Ethics
This retrospective study was performed conform to the Swiss
Human Research Act and was approved by the Bernese
Cantonal Ethics Committee (KEK-Berne, Switzerland).
Magnetic resonance imaging
Several different 1.5 T MR-scanners (Siemens Erlangen,
Germany) from the same manufacturer have been used to
record the apparent diffusion ADC-maps. The images were
recorded typically on a 128  128 image k-space matrix
and interpolated by zero-filling to a 256  256 image
reconstruction matrix. The manufacturers’ standard prod-
uct EPI-pulse sequences with a typical TE ¼ 89 ms and TR
¼ 3000 ms was used. The slice thickness was 5.0 mm with
a gap of 1.5 mm between the slices. The interpolated pixel
size was typically in the order of 1.2  1.2  5.0 mm3.
Since data from various scanners and hospitals were over a
time period of more than 10 years, the MR-acquisition
parameters were not identical in all cases.
Extraction of image features
The CARD method which is used in this article is a radiomics
variant (see e.g. Lambin et al.11), due to the fact that it com-
bines image feature extractionwithmachine learning. Please
refer to the Online Supplementary Material for more details
on the method variant of this article, more specifically, how
exactly the image feature extraction was performed.
RF classifiers in diagnostics
Classifiers can be viewed as algorithms that can decide
between several possible diagnoses, that is, they return the
most likely diagnosis class. The main requirement is that the
patient data used for the training of the classifier are repre-
sentative for de novo patients. In this article, RF classifiers as
proposed by Breiman10 were used. This type of classification
has been used in a large number of studies performed in
different fields of application12,13 and carry a high prediction
accuracy (see e.g., Breiman,10 Liaw and Wiener,14 Strobl
et al.15). The RF consist of several hundred different decision
trees. Each decision tree corresponds to a set of rules that
leads for each feature set to a clear-cut diagnosis along with a
probability measure (in case of equal probabilities for each
diagnosis, the decision is taken at random). Each tree is
trained on a different bootstrap sample of the training data.
During training, the split rules are optimized such that
the training observations with known diagnosis label get
most possible unmixed with regard to their diagnosis
labels. If a new observation follows the decision rules and
ends up in one leaf of the tree, then the probability for a
certain diagnosis is given by the proportion of this diagno-
sis among all training observations corresponding to this
leaf. That diagnosis which gets the majority of the votes of
the RF-classifier is the predicted clinical diagnosis.
The diagnosis of the whole RF is derived by letting the
trees majority prediction vote or by averaging the probabil-
ities over all trees and pick the diagnosis with the highest
probability. Aggregation of many independent and
unbiased predictions yields in general a highly accurate
prediction since the variance of the individual classifica-
tions is averaged out. The performance is given as out-of-bag
(OOB) error, which corresponds to the misclassification rate
of the classifier when each observation is only classified
with that subset of trees that did not have this observation
in the bootstrap training set. Therefore, we expect the OOB
error rate to resemble the test error rate when classifying
completely new patients with the RF.
Application of computer algorithms in neuroradiology to
aid the neuroradiologist in finding the most likely diagnosis
can be called CARD. A software was developed to make
CARD practically feasible in a clinical setting offering the
following functionality: (i) a simple way to create novel
disease specific databases; (ii) add the relevant radiological
data of patients for which histological asserted findings are
available into these databases; (iii) automatic training of RF
classifiers based on this data; and (iv) extracting the same
type of image data for new, for which the diagnosis is
unclear; (v) performing the diagnosis, based on a given
DD formulated by the neuroradiologist. In Figure 2, the prin-
ciple of CARD is displayed. A prototype software for these
purposes was developed in our institute in the programming
language JAVA (version 1.7), using the RCaller-class (ver-
sion 2.0.7)16 to enable the usage of the R-implementation
Breimans’ RF algorithm10 to perform the classification.
Computed texture features
In the first step, the developed computer program computed
for each ADC-map a total of 17 derived texture maps
(see Figure 3 for an illustrative example for a PA). A gra-
phical interpretation of the relationship between the original
ADC-map and its associated texture parameter maps and
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texture parameters is displayed in Figure 4. From these tex-
ture maps, a total of 94 texture parameters are computed.
More details on the computation of the used texture para-
meters are given in the Online Supplementary Material.
Manual tumor segmentation and reproducibility
of classifiers
Three independent raters segmented the tumor volume slice
by slice in the ADC-maps of all 40 included PA, MDB, and
EPM patients, by drawing manually contours that surround
the complete tumor-affected tissue (i.e. solid parts and
edema). Per slice, per contour, and per texture map 94
texture parameters are computed. The number of pixels
within one contour defines the weighting factor for compu-
tation of the averaged mean value of the parameter over all
slices. In this fashion, 94 texture parameters are obtained
per patient to characterize the tumor. These values are the
input features of the RF algorithm.
Measures for neuroradiological diagnostic
performance
To investigate the diagnostic neuroradiological performance
in our department, we retrospectively analyzed the neuror-
adiological diagnostic texts, stored in our institutes’ Radi-
ological Information System (RIS)-system for all study
patients. All diagnostic texts in our institute are based upon
the four-eyes principle, where a junior neuroradiologist and
a senior neuroradiologist analyze all images of the examina-
tion. Additionally, the final diagnostic text is approved by a
senior neuroradiologist.
To evaluate the diagnostic performance, we created a diag-
nostic score (DS). Three possible situations were discrimi-
nated: (1) the neuroradiological diagnosis was correct and
identical with the histological and the best possible DS ¼
100% is assigned; (2) the correct DD was within the formu-
lated stating N-possible DD set and therefore a DS ¼ (100/
N)% is assigned (see Tables 7 to 9 for all DDs mentioned). It
should be noted that this definition possibly underestimates
the true neuroradiological performance, since the order in
which the DDs were formulated is not taken into account;
and (3) the radiological (differential-) diagnosis was wrong
and a DS ¼ 0% is assigned. Finally, an average DSmean was
calculated per disease by the summation of all patient DS
values and divided by the total number of patients in this
group. The written neuroradiological diagnostic findings of
patients who received their initial preoperative MRI scan in
other institutions than ours were requested.
Results
Study population
A total of 40 patients were retrospectively analyzed. All
patients received their preoperative MRI scan from January
Figure 2. Principle of CARD. The extracted image and clinical data of N patients having histologically certified tumor diagnosis are
stored into a database. With these data, RF classifiers can be computed for any given DD. For the (Nþ 1)th patient, for which only a DD
can be defined, the same image-related parameters are extracted. With these data and the DD, the RF classifier computes the most
likely diagnosis. CARD: computer-aided radiological diagnostics; DD: differential diagnosis; RF: random forests.
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2005 until July 2015. A total of 14 PAs, 16 MDBs, and 10
EPMs were included. Quantitative textural information was
extracted from ADC-maps described above. For demo-
graphics, please see Table 1.
Comparison of average tumor ADC values
In addition to the textural analysis, the group-mean ADC
values for the three different tumor types were computed
and are listed in Table 2. For the three different tumor
types, a significant difference between group-means was
found regarding the tumor average ADC values. Equivalent
values are reported by other authors in the past.1,9,17
To further assess where the ADC differences between
the three tumor types arise, we used the Wilcoxon rank sum
test for two-group comparisons. The Benjamini–Hochberg
method to correct for multiple testing was used. Strong
evidence for differences in ADC group-means when
comparing PA versus MDB or EPM versus MDB with
p < 0.001 (see Table 3) was found.
Intra- and inter-rater reliability
We base this reliability analysis on the two-group compar-
ison of PA versus MDB.
Inter-rater variability. Three raters (R.1, R.2, and R.3) have
segmented the tumors and used the RF classification for a
CARD diagnosis. The Fleiss’ kappa test used to quantify
the agreement of the diagnosis results revealed a  ¼ 0.821
with z ¼ 7.79, and a p value ¼ 6.88  1015 (Subjects ¼
30). For a graphical interpretation of the classifier perfor-
mance as a function of the rater, the confusion matrix is
displayed in Table 4.
Intra-rater variability. One rater has segmented the tumors on
three different days one time and used the RF classification
of each segmentation to obtain three times a separate
CARD diagnosis for the same case. The Fleiss’ kappa test
used to quantify the agreement of the diagnosis results
revealed a  ¼ 0.822 with z ¼ 7.15 and p value ¼ 6.22
Figure 3. Texture maps of the ADC-values of a patient suffering from PA. The image shows the ADC-map itself, all 17 texture
parameter maps that are output of the developed software. All maps were color-coded using a rainbow color map lookup table: highest
values in red, lowest values in blue. PA: pilocytic astrocytoma; ADC: apparent diffusion coefficient.
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 1015 (subjects ¼ 30). The confusion matrix is also
given in Table 4.
From this, we can conclude that the inter-rater as well as
the intra-rater agreement is very high.
Classification performance
The overall classification-error rate performance for five
times repetitive contouring (thus averaging over inter- and
intra-rater results) was 11.3+ 2.7%. The average sensitiv-
ity was 0.888 + 0.031 and the average specificity was
0.886+ 0.036 and together with the individual scores they
are listed in Table 5.
Diagnostic performance of the RF-based CARD
method
In Tables 5 and 6, the performance of the classifiers to
distinguish between MDBs, PAs, and EPM are
 For the MDB versus PA DD, an average sensitivity
of 0.888+ 0.031, an average specificity of 0.886+
0.036, and an accuracy of 88.0 + 3.0% was
obtained, with an OOB error rate of 11.3 + 2.7%
(Table 5). The intra-rater variability alone was addi-
tionally computed, and a mean sensitivity of 0.896
+ 0.042 was obtained; for inter-rater variability of
the sensitivity, a value 0.882 + 0.036 was found.
For the intra-rater variability of the specificity, a
value of 0.929 + 0.041, and for inter-rater specifi-
city, a value of 0.893+0.040 was found.
 The EPM versus MDB DD was not part of the repro-
ducibility study, and the classifier was determined
only once. A sensitivity of 0.938 with 95% CI range
of (0.677, 0.996), and a specificity of 0.70 with 95%
CI range of (0.353, 0.919), the mean accuracy was
84.6% and the mean OOB error rate was 15.38%
(Table 6).
 Also for the PA versus EPM, DD was not part of the
reproducibility study but the performance of the
classifier was determined. Here a sensitivity of
0.786 with 95% CI (0.488, 0.943), specificity was
only 0.100 with a 95%CI (0.005, 0.459) (see Table 6),
and the mean accuracy as well as the OOB error
were both 50%.
Clinical differential diagnostic performance
Tables 7 to 9 list the diagnostic performance of neurora-
diologist to diagnose the tumor types correctly. The neu-
roradiologists had access to all multiparametric images of
the complete MR-examination (including at least T1, T1,c,
T2, FLAIR, and ADC imaging). However, the neuroradiol-
ogists had to decide between all possible tumor types,
which is a much more demanding task than CARD as
Figure 4. Graphical model of the relationship between the measured ADC-map (red box, also denoted as ORIG), the texture
parameter maps computed from it (yellow boxes), and finally the texture parameters (green ellipsoid) that were taken as feature inputs
of the RF classification algorithm. ADC: apparent diffusion coefficient; RF: random forest.
Table 1. Demographical data: sex (male:female), and mean age in
years + standard error of patients with different tumor types.
Feature PA EPM MDB
Sex (M:F) 5:9 5:6 10:6
Age in years
(mean + std error)
9.1+ 4.1 45.2 + 15.5 13.1+ 7.5
PA: pilocytic astrocytoma; MDB: medulloblastoma; EPM: ependymoma.
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described here, namely to decide between given disease
alternatives.
The best performance was obtained for the diagnosis
of MDB, for which in 31.25% of the cases there was a
single correct diagnosis, and in 37.5% of the cases a
correct DD was formulated: therefore in a total of
68.75% of the cases, the diagnosis contained MDB as
alternative. The DD score DSmean was 46.9%, weighting
the DS with the amount of differentials stated by the
neuroradiologist (see the definition above).
Second best diagnostic performance was obtained for
PA, with only 14.3% correct diagnoses and 50.0% stat-
ing the correct DD (making 64.3% correct or correct
DD). However for PA, a DD score DSmean of 30.5%
was obtained.
For radiologists, the most difficult diagnosis seems to
be that of EPM. Here only a correct radiological diag-
nosis score of 10% was obtained and in 20%, a correct
DD. This makes a total of only 30% for correct or
correct DD. With a DD score DSmean of just 17.6%, it
is clear that diagnosis of this type of brain tumor is the
most difficult to diagnose out of the three types exam-
ined in this article.
Discussion
Observed ADC values
We have determined the ADC-mean values and standard
deviations for PA, EPM, and MDB and obtained results
which are comparable to the ADC values published earlier
in a pediatric cohort study and other studies2,9,1,18 despite
the high age variation in our group. MDB showed signifi-
cantly lower ADC values than PA and EPM, whereas EPM
and PA showed similar ADC values not finding evidence
for significant different mean values.
Clinical routine tumor DD performance
Tables 7 to 9 give insight into the performance of tumor
diagnostics in daily routine. Neuroradiologists give infre-
quently preoperative clear-cut diagnosis. In our study with
40 patients, correct and clear-cut diagnosis was given for
31% of 16 MDB tumors, 14.3% of 14 PA tumors, and 10%
of 10 EPM tumors. Most of the diagnosis comprises several
tumor types and together with the clear-cut diagnosis the
neuroradiologists diagnosis contained the right tumor in
69% of true MDB, 64% of true PA, and 30% of true EPM.
DD scores DSmean for the three tumor types were deter-
mined and are listed in Table 6. With a DSmean of 57% for
MDBs, this tumor type was best distinguished and most
frequently correct, on average the DD contained less than
two alternatives. For PAs, on average nearly three possible
tumor types were formulated in the DDs, and for EPMs
even more than three tumor type differentials were formu-
lated. These numbers show that visual discrimination of
these tumor entities is an extremely challenging task for
the human visual system, even having access to multiple
MR modalities beside the ADC-maps.
Computer-aided radiological diagnostics
It should be noted that the CARD-algorithms starts with a
DD formulated by a neuroradiologist. For the clinical
important DDs of MDB versus PA and EPM versus MDB,
useful RF classifiers could be developed. For the DD
between MDB and PA, the best performance was observed,
namely an average sensitivity of 0.888+ 0.031 and speci-
ficity of 0.886 + 0.036 with an average classifier OOB
error of 11.3+ 2.7%. This means that for this DD, appli-
cation of CARD could substantially improve radiological
diagnostic quality. The DD between EPM and MDB, how-
ever, was little less performing, with a sensitivity of 0.938
and specificity of 0.700 together with accuracy of 84.6%.
For the DD between PA and EPM, which has a sensi-
tivity of 78.6%, a specificity of only 10% was found. With
such a poor performance, it is clear that such a classifier
cannot be used in practice. One has to conclude from this
that PA and EPM do not differ sufficiently in ADC-
heterogeneity parameters in such a way that they could
be used to distinguish these diseases from each other’s in
a meaningful way. A substantial improvement is expected
in case more data and additional image series of the MRI-
examination (e.g. perfusion imaging) are provided for the
RF training and classification.
Table 2. ADC values (in 106 mm2/s) information grouped by disease type and a p value corresponding to an ANOVA testing for
differences between all three groups.
ADC PA EPM MDB ANOVA p value
Mean+ standard error 1575.5 + 326.7 1433.3+ 285.3 910.5+ 131.9 2.74  105
Range (min–max) 751.1 – 2319.1 938.8 – 2244.3 572.9 – 1264.7
ADC: apparent diffusion coefficient; PA: pilocytic astrocytoma; MDB: medulloblastoma; EPM: ependymoma; ANOVA: analysis of variance.
Table 3. Results of two-group comparison of ADC values given
as multiple testing corrected p values from Wilcoxon rank sum
tests.
Differential diagnosis p value
PA versus MDB 0.000028
EPM versus MDB 0.00021
EPM versus PA 0.28468
ADC: apparent diffusion coefficient; PA: pilocytic astrocytoma; MDB:
medulloblastoma; EPM: ependymoma.
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Dependency of CARD results on rater segmentation
Since the CARD method depends on manual segmentation
of the complete tumor-affected area, the classification per-
formance could, in principle, strongly depend on the indi-
vidual segmentation of each individual rater. Therefore, a
reliability analysis was performed to investigate the repro-
ducibility of the CARD diagnosis. For the inter- and
intra-rater reproducibility, a Fleiss’ kappa test value of
 ¼ 0.821, 0.822, respectively, was found, which means
that there is a very high agreement in obtained classifiers.19
Since the inter-rater and intra-rater reproducibility seems to
Table 4. Confusion matrix for the inter-rater and intra-rater reproducibility of the CARD method applied to the DD of MDB
versus PA.
Inter-rater comparison Intra-rater comparison
Patient number Rater 1 Rater 2 Rater 3 Ground truth First Second Third
1 MDB MDB MDB MDB MDB MDB MDB
2 MDB MDB PA MDB MDB PA MDB
3 MDB MDB MDB MDB MDB MDB MDB
4 MDB MDB MDB MDB MDB MDB MDB
5 MDB MDB MDB MDB MDB MDB MDB
6 MDB MDB MDB MDB MDB MDB MDB
7 MDB PA PA MDB MDB PA MDB
8 MDB MDB MDB MDB MDB MDB MDB
9 MDB MDB MDB MDB MDB MDB MDB
10 MDB MDB MDB MDB MDB MDB MDB
11 MDB MDB MDB MDB MDB MDB MDB
12 MDB MDB MDB MDB MDB MDB MDB
13 MDB MDB MDB MDB MDB MDB MDB
14 PA PA PA MDB PA PA PA
15 MDB MDB MDB MDB MDB MDB MDB
16 MDB MDB MDB MDB MDB MDB MDB
17 PA PA PA PA PA PA PA
18 PA PA PA PA PA MDB PA
19 PA PA PA PA PA PA PA
20 MDB MDB MDB PA PA MDB MDB
21 PA MDB MDB PA PA PA PA
22 PA PA PA PA PA PA PA
23 PA MDB MDB PA PA PA PA
24 PA PA PA PA PA PA PA
25 PA PA PA PA PA PA PA
26 PA PA PA PA PA PA PA
27 PA PA PA PA PA PA PA
28 PA PA PA PA PA PA PA
29 PA PA PA PA PA PA PA
30 PA PA PA PA PA PA PA
CARD: computer-aided radiological diagnostics; PA: pilocytic astrocytoma; MDB: medulloblastoma; EPM: ependymoma.
Table 5. The variability on the classification performance parameters (sensitivity, specificity with their CI boundaries CI-min and
CI-max) due to inter-rater and intra-rater differences in contouring was examined for the DD of MBD versus PA.a
DD, MDB versus PA R1.1 R1.2 R1.3 R2 R3 Overall classifier performance (Average + Standard error)
Sensitivity 0.938 0.813 0.938 0.938 0.813 0.888 + 0.031
CI-min 0.677 0.537 0.667 0.677 0.537 0.619 + 0.033
CI-max 0.997 0.950 0.997 0.997 0.950 0.978 + 0.012
Specificity 1.000 0.857 0.929 0.786 0.857 0.886 + 0.036
CI-min 0.699 0.562 0.642 0.488 0.562 0.591 + 0.036
CI-max 1.000 0.950 0.996 0.943 0.975 0.973 + 0.012
OOB estimate of error rate (%) 3.33 6.67 16.67 13.3 16.7 11.3 + 2.7
CI: confidence interval; DD: differential diagnosis; PA: pilocytic astrocytoma; MDB: medulloblastoma; OOB: out-of-box; CI-min: minimal 95% confidence
range; CI-max: maximal 95% confidence range.
aR1.1, R1.2, and R1.3 refer to one single rater doing three different evaluations and reveals information on the intra-rater variability. Raters R1, R2, and
R3 are three different independent raters and reveals information on the inter-rater variability. The errors indicated are standard errors.
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Table 6. RF classifier performance of the classifiers for the DD of
PA versus MDB and EPM versus PA.a
DD Value CI-min CI-max Accuracy
EPM versus MDB
Sensitivity 0.938 0.677 0.997
Specificity 0.700 0.354 0.919
OOB estimate of error rate 15.38%
Accuracy 84.6%
EPM versus PA
Sensitivity 0.786 0.488 0.943
Specificity 0.100 0.005 0.459
OOB estimate of error rate 50%
Accuracy 50%
CI: confidence interval; DD: differential diagnosis; PA: pilocytic astrocy-
toma; MDB: medulloblastoma; OOB: out-of-box; RF: Random Forest;
CI-min: minimal 95% confidence range; CI-max: maximal 95% confidence
range.
aThe best classification performance obtained is indicated. Apart from the
sensitivity and specificity, the OOB error rate estimates are indicated.
Table 7. Histological diagnosis compared to the radiological
diagnosis for PA.
PA
Absolute
patient
numbers
Percentage
(%)
Total number of patients 14 100
Correct radiological diagnosis 2 14.3
Correct differential radiological
diagnosis
7 50.0
Wrong radiological diagnosis 5 35.7
DD score DSmean 30.5%
Posed radiological DDs by tumor type
Number
of times
Rel. %
of DD
PA 9 26.5
Glioma WHO Grade-II 4 11.8
Glioma WHO Grade-III 3 8.8
Glioma WHO Grade-IV 2 5.9
Craniopharyngioma 1 2.9
Germinoma 1 2.9
Schwannoma 1 2.9
PNET 1 2.9
MDB 1 2.9
EPM 2 5.9
Hemangioblastoma 1 2.9
Neurinoma 1 2.9
MDB 2 5.9
Neurofibromatosis 1 2.9
Hippel–Lindau syndrome 1 2.9
Epidermoid 1 2.9
Teratoma 1 2.9
Unknown lesion 1 2.9
Total number of differential diagnoses 34 100
PA: pilocytic astrocytoma; MDB: medulloblastoma; EPM: ependymoma;
DD: differential diagnosis; DS: diagnostic score; PNET: Primitive NeuroEc-
todermal Tumor; WHO: World Health Organization.
Table 8. Histological diagnosis compared to the radiological
diagnosis for EPM.
EPM
Absolute
patient
numbers
Percentage
(%)
Total number of patients 10 100
Correct radiological diagnosis 1 10.0
Correct radiological differential
diagnosis
2 20.0
Wrong radiological diagnosis 7 70.0
DD score DSmean 24 differentials 17.6
Posed radiological DD by tumor
types
Number
of times
Rel. %
of DD
EPM 3 12.5
MDB 1 4.2
PA 5 20.8
Glioma WHO Grade-II 1 4.2
Glioma WHO Grade-III 2 8.3
Glioma WHO Grade-IV 2 8.3
Subependymal giant cell
astrocytoma
1 4.2
Plexus choroid papilloma 2 8.3
Ganglioglioma 1 4.2
Hemangioblastoma 1 4.2
Metastasis 3 12.5
Meningioma 2 8.3
Total number of differentials 24 100
PA: pilocytic astrocytoma; MDB: medulloblastoma; EPM: ependymoma;
DD: differential diagnosis; DS: diagnostic score.
Table 9. Histological diagnosis compared to the radiological
diagnosis for MDB.
MDB
Absolute
patient
numbers
Percentage
(%)
Total number of patients 16 100
Correct radiological diagnosis 5 31.25
Correct differential radiological
diagnosis
6 37.50
Wrong radiological diagnosis 5 31.25
DD score DSmean 46.9
Posed radiological differential diagnoses
by tumor type
Number
of cases
Rel.%
of DDs
MDB 11 31.4
PNET 3 8.6
PA 5 14.3
EPM 5 14.3
Meningioma 2 5.7
Lymphoma 2 5.7
Plexus papilloma 1 2.9
Metastasis 3 8.6
Glioma WHO-III 1 2.9
Glioma WHO-IV 1 2.9
Unknown lesion 1 2.9
Total number of differentials 35 100
PA: pilocytic astrocytoma; MDB: medulloblastoma; EPM: ependymoma;
DD: differential diagnosis; DS: diagnostic score.
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be nearly identical, one may conclude that small differ-
ences in the human contoured tumor volumes do not really
affect classification performance. Additionally one rater
can reproduce its contouring as good as different raters
among each other’s. It can be concluded that the task to
segment to “whole tumor affected volume” can be repro-
duced to a high level of agreement.
Diagnostic performance of machine versus man
For the presented CARD method, it is not possible to
directly compare the diagnostic performance of the
machine to the human diagnostic performance. We want
to emphasize that the success of any CARD method
depends on the posed DD by the neuroradiologist, that
is, a DD in which the correct diagnosis needs to belong
to the solution set. The performance of the RF is quanti-
fied by the probability to find the correct diagnosis within
a DD. This probability is given by one minus the OOB-
class error. However, in practice, this performance needs
to be down-corrected with the probability of a correctly
posed DD by the neuroradiologist (see Tables 7 to 9).
Moreover, neuroradiologists frequently indicate in their
DD more than two options (DSmean takes into account the
number of options). In these cases, several trained RFs
need to be applied to determine which tumor we are deal-
ing with.
Practical benefit of CARD
In practice, knowing the tumor type is critical for the
therapeutic option stratification, for example, deciding
and planning the extent of resection. However, based on
MRI scans, neuroradiologists can often give only a set of
possible tumor types. In such cases, the presented CARD
results are valuable. Since the presented semiautomatic
statistical method for CARD can be performed time-
efficiently, it is feasible for the usage in clinical practice.
The accuracy of the method can be further improved by
also taking other modalities into account, for example,
textural information derived from FLAIR or T1c-imaging.
Combination with complete automatic segmentation algo-
rithms like Porz et al.20 could improve the reproducibility
of the method further.
Limitations
Our patient collective is relatively small for further sub-
classification or investigation of genetic differences. Again
one should realize that a classifier can only be used for the
purpose it has been trained. The classifier can only provide
more confidence about the diagnosis, if the DD includes the
correct diagnosis. It should be noted that this is not only the
case for the proposed CARD but is true for all machine
learning-based classifiers.
Conclusions
Reproducible and highly accurate, sensitive and specific
classifiers for CARD can be obtained by feeding texture
parameters extracted of ADC-maps only into an RF classi-
fication algorithm for deciding which brain tumor is most
likely in the DDs of PA versus MDB or MDB versus EPM.
For the DD of PA versus EPM, the classifiers were less
accurate, specific, and sensitive but still can be used to
improve the clinical neuroradiological diagnostics. Inter-
esting aspect of the presented CARD method is the fact
that all data of the past can simply be used to enhance the
diagnostics of future patients.
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